Summary: Africa CDC Director-General Dr Jean Kaseya has called out the glaring double standard in global health response, saying if the current Ebola outbreak were happening in Western nations, approved vaccines would already be on the ground.
There is a painful truth that many Africans have long suspected but rarely heard spoken so boldly from the corridors of power — and now, the Director-General of the Africa Centres for Disease Control and Prevention (Africa CDC), Dr Jean Kaseya, has finally said it out loud.
According to Dr Kaseya, if the current Ebola outbreak were unfolding in a Western country — think France, the United Kingdom, or the United States — approved vaccines would already be available and deployed. But because it is happening on African soil, the world is moving at a different pace entirely.
The Double Standard Nobody Wants to Admit
This is not a new conversation. Nigerians and other Africans have watched this pattern play out time and time again. When COVID-19 hit, wealthy nations secured billions of vaccine doses even before clinical trials were completed, while African countries were left scrambling on waiting lists. When monkeypox began spreading in Europe and North America, emergency use authorisations and vaccine rollouts happened with remarkable speed.
Now, as Ebola continues to claim lives on the continent, the question Dr Kaseya is asking is simple but devastating: Why is Africa always last?
Who Is Dr Jean Kaseya?
Dr Jean Kaseya is not a man who speaks carelessly. As the Director-General of Africa CDC — the continent’s premier public health institution — his words carry enormous weight. When he raises the alarm about the absence of an approved Ebola vaccine during an active outbreak, the global health community must listen.
His frustration reflects the broader anger felt across African nations — from Lagos to Kinshasa, from Nairobi to Accra — that the continent continues to be treated as an afterthought in global health planning, despite being home to over 1.4 billion people.
What This Means for Nigeria and the Rest of Africa
For Nigerians, this issue hits close to home. Nigeria has had its own harrowing encounters with Ebola. In 2014, we watched in collective horror as the virus entered Lagos — Africa’s largest city — through a single traveller. It was only through extraordinary effort, community vigilance, and professional dedication by our health workers that a catastrophic outbreak was averted.
But here is the uncomfortable reality: we survived 2014 largely on bravery, not on the kind of robust vaccine infrastructure that wealthier nations take for granted.
If another major Ebola outbreak were to reach our shores today, would we be better protected? Dr Kaseya’s comments suggest the answer remains deeply uncertain.
The Bigger Picture — Health Equity Is Not a Luxury
The Africa CDC boss is essentially calling for health equity — the radical idea that an African life is worth just as much as a European or American one.
This is not about begging for handouts. It is about demanding that:
– Research and development for diseases that predominantly affect Africa receive adequate funding
– Regulatory pathways for vaccines are not slower simply because the affected populations are African
– African nations invest more aggressively in building their own pharmaceutical and vaccine manufacturing capacity
Nigeria, for its part, has been making strides. The Dangote Group and the Federal Government have both pointed to the need for local vaccine production. The African Union’s Agenda 2063 includes ambitions for pharmaceutical self-sufficiency. But ambition and action are two different things.
The Challenge We Must Accept
Dr Kaseya’s statement is not just a critique of the West — it is also a challenge to African governments, policymakers, and citizens. We cannot continue to outsource our health security to countries that will always, understandably, prioritise their own populations first.
The lesson from COVID-19, from Ebola, from every health crisis that has swept through this continent, is the same: Africa must build its own capacity, fund its own research, and fight for its own place at the global health table.
Until then, we will continue to wait — and waiting, as we have seen far too many times, costs lives.
What do you think? Should African nations be doing more to develop their own vaccines and health infrastructure? Drop your thoughts in the comments below.
Uncover more updates on buzzUp9ja
Be the first to comment